Combined oral contraceptives, thrombophilia and the risk of venous thromboembolism: a systematic review and meta‐analysis
- 1 July 2016
- journal article
- research article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 14 (7) , 1393-1403
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databasesBMJ, 2015
- Combined oral contraceptives: venous thrombosisCochrane Database of Systematic Reviews, 2014
- The venous thrombotic risk of oral contraceptives, effects of oestrogen dose and progestogen type: results of the MEGA case-control studyBMJ, 2009
- Hormonal contraception and risk of venous thromboembolism: national follow-up studyBMJ, 2009
- A study of Protein S antigen levels in 3788 healthy volunteers: influence of age, sex and hormone use, and estimate for prevalence of deficiency stateBritish Journal of Haematology, 2001
- Combined Effect of Factor V Leiden and Prothrombin 20210A on the Risk of Venous ThromboembolismThrombosis and Haemostasis, 2001
- Geographic Distribution of the 20210 G to A Prothrombin VariantThrombosis and Haemostasis, 1998
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995
- World distribution of factor V LeidenThe Lancet, 1995
- Prevalence of antithrombin deficiency in the healthy populationBritish Journal of Haematology, 1994